Weighing risks and benefits of COVID-19 vaccination in children
Research into bacterium causing bubonic plague yields clues to fighting pneumonia, sepsis
2 November 2021FDA authorizes sample pooling for SalivaDirect PCR COVID-19 test
2 November 2021Weighing risks and benefits of COVID-19 vaccination in children
The U.S. Food and Drug Administration has approved Pfizer’s COVID-19 vaccine for use in children ages five to 11. Pfizer’s clinical trial results indicate the vaccine is safe and effective in this age group.
